Allergan to acquire liver drug maker Tobira Therapeutics
MLex Summary: Allergan has agreed to buy liver drug maker Tobira Therapeutics for about $1.7 billion. The transaction is expected to close by the end of 2016.See statement in full below....To view the full article, register now.
Already a subscriber? Click here to view full article